During the past decade, General Hospital Djordje Jovanovic Zrenjanin conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "General Hospital Djordje Jovanovic Zrenjanin" are "Crohn Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Cardiac Failure" (1 trials), "Gastrointestinal Disorders" (1 trials) and "Neuropathic Pain" (1 trials). Many other conditions were trialed in "General Hospital Djordje Jovanovic Zrenjanin" in a lesser frequency.

Most popular intervention types in "General Hospital Djordje Jovanovic Zrenjanin" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "RPC1063" (2 trials), "Cobitolimod 250 mg" (1 trials) and "Cobitolimod 500 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Djordje Jovanovic Zrenjanin" are 8 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital Djordje Jovanovic Zrenjanin". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in General Hospital Djordje Jovanovic Zrenjanin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Djordje Jovanovic Zrenjanin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".